SE465367B - Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar - Google Patents
Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringarInfo
- Publication number
- SE465367B SE465367B SE8603517A SE8603517A SE465367B SE 465367 B SE465367 B SE 465367B SE 8603517 A SE8603517 A SE 8603517A SE 8603517 A SE8603517 A SE 8603517A SE 465367 B SE465367 B SE 465367B
- Authority
- SE
- Sweden
- Prior art keywords
- methyl
- alkyl
- phenyl
- group
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21958/85A IT1201455B (it) | 1985-08-21 | 1985-08-21 | Derivati piridinici sostituiti |
IT19480/86A IT1204458B (it) | 1986-02-20 | 1986-02-20 | Derivati eterociclici |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8603517D0 SE8603517D0 (sv) | 1986-08-20 |
SE8603517L SE8603517L (sv) | 1987-02-22 |
SE465367B true SE465367B (sv) | 1991-09-02 |
Family
ID=26327180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8603517A SE465367B (sv) | 1985-08-21 | 1986-08-20 | Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar |
Country Status (18)
Country | Link |
---|---|
US (1) | US5162345A (fr) |
JP (1) | JPH0696552B2 (fr) |
AT (1) | AT394043B (fr) |
AU (1) | AU588352B2 (fr) |
BE (1) | BE905297A (fr) |
CA (1) | CA1337295C (fr) |
CH (1) | CH669788A5 (fr) |
CY (1) | CY1554A (fr) |
DE (1) | DE3628215C2 (fr) |
DK (1) | DK397686A (fr) |
ES (1) | ES2001104A6 (fr) |
FR (1) | FR2586417B1 (fr) |
GB (1) | GB2181127B (fr) |
IE (1) | IE59632B1 (fr) |
NL (1) | NL192385C (fr) |
NZ (1) | NZ217282A (fr) |
SE (1) | SE465367B (fr) |
SG (1) | SG40890G (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
AU761467B2 (en) * | 1998-06-09 | 2003-06-05 | Ajinomoto Co., Inc. | Novel enzyme-treated protein-containing food, and methods for producing the same |
FR2892412B1 (fr) * | 2005-10-26 | 2008-05-16 | Galderma Res & Dev | Composes biaromatiques modulateurs des ppars |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3455945A (en) * | 1967-06-07 | 1969-07-15 | Smithkline Corp | 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines |
DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
GB1409865A (en) * | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
DE2740080A1 (de) * | 1977-09-06 | 1979-03-15 | Bayer Ag | 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2753946A1 (de) * | 1977-12-03 | 1979-06-13 | Bayer Ag | 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel |
US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
NZ212895A (en) * | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
IT1204462B (it) * | 1986-02-20 | 1989-03-01 | Glaxo Spa | Derivati eterociclici |
DE3607821A1 (de) * | 1986-03-08 | 1987-09-10 | Bayer Ag | Aminoester-dihydropyridine, verfahren zur herstellung und ihre verwendung |
US4814455A (en) * | 1986-04-16 | 1989-03-21 | Bristol-Myers Company | Dihydro-3,5-dicarboxylates |
-
1986
- 1986-08-20 ES ES8601217A patent/ES2001104A6/es not_active Expired
- 1986-08-20 AU AU61668/86A patent/AU588352B2/en not_active Ceased
- 1986-08-20 IE IE222786A patent/IE59632B1/en not_active IP Right Cessation
- 1986-08-20 NL NL8602117A patent/NL192385C/nl not_active IP Right Cessation
- 1986-08-20 FR FR868611893A patent/FR2586417B1/fr not_active Expired - Lifetime
- 1986-08-20 DK DK397686A patent/DK397686A/da not_active Application Discontinuation
- 1986-08-20 NZ NZ217282A patent/NZ217282A/xx unknown
- 1986-08-20 AT AT0223986A patent/AT394043B/de not_active IP Right Cessation
- 1986-08-20 BE BE0/217060A patent/BE905297A/fr not_active IP Right Cessation
- 1986-08-20 SE SE8603517A patent/SE465367B/sv not_active IP Right Cessation
- 1986-08-20 JP JP61192990A patent/JPH0696552B2/ja not_active Expired - Lifetime
- 1986-08-20 GB GB8620217A patent/GB2181127B/en not_active Expired
- 1986-08-20 DE DE3628215A patent/DE3628215C2/de not_active Expired - Fee Related
- 1986-08-20 CA CA000516391A patent/CA1337295C/fr not_active Expired - Fee Related
- 1986-08-20 CH CH3340/86A patent/CH669788A5/de not_active IP Right Cessation
-
1990
- 1990-06-11 SG SG408/90A patent/SG40890G/en unknown
- 1990-08-20 US US07/673,510 patent/US5162345A/en not_active Expired - Fee Related
-
1991
- 1991-03-22 CY CY1554A patent/CY1554A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US5162345A (en) | 1992-11-10 |
DE3628215A1 (de) | 1987-02-26 |
IE59632B1 (en) | 1994-03-09 |
GB2181127B (en) | 1989-08-02 |
NZ217282A (en) | 1989-01-27 |
AU588352B2 (en) | 1989-09-14 |
JPH0696552B2 (ja) | 1994-11-30 |
CA1337295C (fr) | 1995-10-10 |
AU6166886A (en) | 1987-02-26 |
ATA223986A (de) | 1991-07-15 |
IE862227L (en) | 1987-02-21 |
GB8620217D0 (en) | 1986-10-01 |
DK397686A (da) | 1987-02-22 |
DE3628215C2 (de) | 1996-09-19 |
FR2586417B1 (fr) | 1991-08-30 |
GB2181127A (en) | 1987-04-15 |
FR2586417A1 (fr) | 1987-02-27 |
NL8602117A (nl) | 1987-03-16 |
SG40890G (en) | 1990-08-03 |
CY1554A (en) | 1991-03-22 |
NL192385C (nl) | 1997-07-04 |
AT394043B (de) | 1992-01-27 |
JPS6296467A (ja) | 1987-05-02 |
BE905297A (fr) | 1987-02-20 |
CH669788A5 (fr) | 1989-04-14 |
SE8603517D0 (sv) | 1986-08-20 |
NL192385B (nl) | 1997-03-03 |
ES2001104A6 (es) | 1988-04-16 |
SE8603517L (sv) | 1987-02-22 |
DK397686D0 (da) | 1986-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6001836A (en) | Dihydropyridine NPY antagonists: cyanoguanidine derivatives | |
HU187868B (en) | Process for producing dihydropyridine derivatives | |
US5670525A (en) | Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders | |
EP0097821B1 (fr) | Dihydropyridines douées d'une activité antagoniste pour le calcium, leur procédé de préparation et leur application dans des compositions pharmaceutiques | |
US6057332A (en) | Substituted 1,4-dihydropyrimidine-5-carboxylate compounds, their preparation and uses | |
EP0215250B1 (fr) | 1,4-Dihydropyridines substitués en position 2, leur procédé de préparation et compositions pharmaceutiques les contenant | |
SE465367B (sv) | Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar | |
CA1208639A (fr) | Derives de 1,4-dihydropropyridine, optiquement actifs ou sous forme de racemique; preparation et compositions pharmaceutiques | |
CZ217495A3 (en) | 2,3-cyclically condensed 1,4-dihydropyridines, process of their preparation, medicaments in which said substances are comprised and their use | |
EP0245919B1 (fr) | Dérivés de la dihydro-1,4 pyridine | |
EP0245918B1 (fr) | Dérivés de la dihydro-1,4 pyridine | |
US4491582A (en) | N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid | |
CA1323876C (fr) | Derives de dihydropyridine; compositions pharmaceutiques a base de ces derives | |
KR950011410B1 (ko) | 헤테로사이클릭 화합물의 제조방법 | |
EP0238211B1 (fr) | Dihydropyridines, leur procédé de préparation et leur utilisation comme médicaments | |
JPH0240383A (ja) | 1,4−ジヒドロピリジン誘導体 | |
SK158095A3 (en) | Application of 1,2-bridged 1,4-dihydropyridines, 1,2-bridged 1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them | |
EP0242950B1 (fr) | Dihydropyridines, leur procédé de préparation et leur utilisation comme médicaments | |
RU1816282C (ru) | Способ получени производных 2-аминоалкилтиометил-1,4-дигидропиридина или их энантиомеров | |
NO174419B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser | |
HU198907B (en) | Process for producing dihydropyridine derivatives and pharmaceutical compositions containing them as active components | |
US5652251A (en) | 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation | |
EP0479665A2 (fr) | 1,4-Dihydropyridines, procédé pour leur préparation et utilisation | |
古林隆司 et al. | Novel 2-Amino-1, 4-dihydropyridine Calcium Antagonists. II. Synthesis and Antihypertensive Effects of 2-Amino-1, 4-dihydropyridine Derivatives Having N, N-Dialkylaminoalkoxycarbonyl Groups at 3-and/or 5-Position. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8603517-7 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8603517-7 Format of ref document f/p: F |